Antengene Corporation Limited 德琪醫藥有限公司

Pay for financial year ended 2021-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Alles, Mark John INED 645 522 1,167
2 Cao, Yanling 曹彥凌 NED
3 Chen, Kan (1981) 陳侃 NED
4 Chin, John Francis ED 2,409 723 310 1,722 5,164
5 Hu, Xubo 胡旭波 NED
6 Li, Zhen (1979) 李甄 NED
7 Liu, Yilun (1986) 劉逸倫 NED
8 Liu, Yiteng 劉翼騰 ED, COO 793 36 3,757 4,586
9 Lung, Donald Andrew 龍振國 FD 1,212 660 97 68 2,037
10 Lynch, Kevin Patrick (1965-01) ED 1,427 360 60 205 2,052
11 Mei, Jay 梅建明 Ch, CEO 4,997 5,084 615 6,076 16,772
12 Qian, Jing (1976) 錢晶 INED 323 23 346
13 Tang, Sheng (1983) 唐晟 INED 323 23 346
Total 1,291 10,838 6,827 1,118 12,396 32,470

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,176 12,557 3,611 1,237 3,841 22,422 Report
2023-12-31 1,316 12,980 3,998 1,293 11,786 31,373 Report
2022-12-31 1,401 14,734 3,963 1,627 14,918 36,643 Report
2021-12-31 1,291 10,838 6,827 1,118 12,396 32,470 Report
2020-12-31 690 6,749 7,607 969 86,863 102,878 Report
Total 5,874 57,858 26,006 6,244 129,804 225,786

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Webb-site.com was originally created by David M Webb MBE

We are committed to maintaining high quality and expanding the database with additional data and insight.

Back to top